HIV Pre-Exposure Prophylaxis and Postexposure Prophylaxis in Japan: Context of Use and Directions for Future Research and Action.
Biomedical HIV prevention strategies are playing an increasingly prominent role in addressing HIV epidemics globally, but little is known about their use in Japan, where persistent HIV disparities and a recently stable, but not declining, national epidemic indicate the need for evolving approaches. We conducted an ethnographic study to determine the context of pre-exposure prophylaxis (PrEP) and postexposure prophylaxis (PEP) use and to identify directions for future research and action in Japan. We used data from observational fieldwork in the Kansai region and Tokyo Metropolitan Area (n = 178 persons observed), qualitative interviews (n = 32), documents and web-based data sources (n = 321), and email correspondences (n = 9) in the period 2013-2016. Drug approvals by Japan's regulatory agencies, insurance coverage for medications, and policies by healthcare institutions and government agencies were the main factors affecting PrEP and PEP legality, use, and awareness. Awareness and the observable presence of PrEP and PEP were very limited, particularly at the community level. PrEP and PEP held appeal for Japanese scientists and activists, and for study participants who represented various other stakeholder groups; however, significant concerns prevented open endorsements. Japanese health officials should prioritize a national discussion, weigh empirical evidence, and strongly consider formal approval of antiretroviral (ARV) medications for use in PrEP and both occupational and nonoccupational PEP. Once approved, social marketing campaigns can be used to advertise widely and increase awareness. Future research would benefit from theoretical grounding in a diffusion of innovations framework. These findings can inform current and future ARV-based prevention strategies at a critical time in the international conversation.
1 Department of Health Science, California State University , Fullerton, Fullerton, California.
Anthony S
AS
DiStefano
2 Program in Comparative Cultures, Graduate School of Humanities, Josai International University , Togane, Japan .
Makiko
M
Takeda
D000163:Acquired Immunodeficiency Syndrome / Q000517:prevention & control; D005260:Female; D015658:HIV Infections / Q000517:prevention & control*; D006282:Health Personnel; D006801:Humans; D007564:Japan; D008297:Male; D056990:Post-Exposure Prophylaxis / Q000379:methods*; D065129:Pre-Exposure Prophylaxis / Q000379:methods*; D036301:Qualitative Research; D012106:Research / Q000639:trends*; D014041:Tokyo
HIV; Japan; PEP; PrEP; biomedical prevention; ethnographic